217 related articles for article (PubMed ID: 8625120)
1. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
Suehiro T; Matsumata T; Itasaka H; Yamamoto K; Kawahara N; Sugimachi K
Cancer; 1995 Aug; 76(3):399-405. PubMed ID: 8625120
[TBL] [Abstract][Full Text] [Related]
2. Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma.
Suehiro T; Matsumata T; Itasaka H; Taketomi A; Yamamoto K; Sugimachi K
Surgery; 1995 Jun; 117(6):682-91. PubMed ID: 7539944
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia.
Adachi E; Hashimoto H; Tsuneyoshi M
Cancer; 1993 Nov; 72(10):2902-9. PubMed ID: 8106139
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
Hino N; Higashi T; Nouso K; Nakatsukasa H; Urabe Y; Kinugasa N; Yoshida K; Ashida K; Ohguchi S; Tsuji T
Hepatogastroenterology; 1997; 44(13):245-50. PubMed ID: 9058153
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma.
Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK
Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246
[TBL] [Abstract][Full Text] [Related]
6. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis.
Kitamoto M; Nakanishi T; Kira S; Kawaguchi M; Nakashio R; Suemori S; Kajiyama G; Asahara T; Dohi K
Cancer; 1993 Sep; 72(6):1859-65. PubMed ID: 8103417
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hepatic proliferative activity in chronic liver diseases and hepatocellular carcinomas by proliferating cell nuclear antigen (PCNA) immunohistochemical staining of methanol-fixed tissues.
Nakajima T; Kagawa K; Ueda K; Ohkawara T; Kimura H; Kakusui M; Deguchi T; Okanoue T; Kashima K; Ashihara T
J Gastroenterol; 1994 Aug; 29(4):450-4. PubMed ID: 7951855
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen.
Ng IO; Na J; Lai EC; Fan ST; Ng M
Am J Clin Pathol; 1995 Sep; 104(3):313-8. PubMed ID: 7545866
[TBL] [Abstract][Full Text] [Related]
9. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépatocellulaire.
Chapel F; Guettier C; Chastang C; Rached AA; Mathieu D; Tepper M; Beaugrand M; Trinchet JC
Cancer; 1996 Mar; 77(5):864-71. PubMed ID: 8608476
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
Hu TH; Wang CC; Huang CC; Chen CL; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Tai MH
Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
[TBL] [Abstract][Full Text] [Related]
11. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
Saiki I; Une Y; Uchino J
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.
Tiniakos DG; Brunt EM
Liver; 1999 Feb; 19(1):58-68. PubMed ID: 9928768
[TBL] [Abstract][Full Text] [Related]
13. Growth kinetic study of human hepatocellular carcinoma using proliferating cell nuclear antigen and Lewis Y antigen: their correlation with transforming growth factor-alpha and beta 1.
Yamaguchi M; Yu L; Hishikawa Y; Yamanoi A; Kubota H; Nagasue N
Oncology; 1997; 54(3):245-51. PubMed ID: 9143407
[TBL] [Abstract][Full Text] [Related]
14. The expression of proliferating cell nuclear antigen in hepatocellular carcinoma.
Wu JD; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):198-203. PubMed ID: 7911731
[TBL] [Abstract][Full Text] [Related]
15. Tissue hepatocyte growth factor and proliferating cell nuclear antigen in hepatocellular carcinoma.
Huang GT; Lee HS; Chen CH; Chiou LL; Lee CZ; Chen DS; Hsu HC; Sheu JC
J Formos Med Assoc; 1999 Feb; 98(2):92-6. PubMed ID: 10083763
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
Osada S; Saji S; Kuno T
J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
[TBL] [Abstract][Full Text] [Related]
17. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
Guo RP; Yu WS; Wei W
Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
Choi HJ; Jung IK; Kim SS; Hong SH
Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
[TBL] [Abstract][Full Text] [Related]
19. Computerized nuclear morphometry of hepatocellular carcinoma and its relation to proliferative activity.
Ikeguchi M; Sato N; Hirooka Y; Kaibara N
J Surg Oncol; 1998 Aug; 68(4):225-30. PubMed ID: 9721707
[TBL] [Abstract][Full Text] [Related]
20. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
Mun KS; Cheah PL; Baharudin NB; Looi LM
Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
